









시장가
/
주식
/
nasdaq-mlab
/

Mesa Laboratories Inc

MLAB

80.470USD

-0.200-0.25%

종가 12/26, 16:00（ET）시세는 15분 지연됩니다

443.45M시가총액

손실P/E TTM



Mesa Laboratories Inc

80.470

-0.200-0.25%

개요 회사 금융 분석

개요

회사

금융

분석

자세한 내용은 Mesa Laboratories Inc 회사

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.

Mesa Laboratories Inc 정보



종목 코드 MLAB

회사 이름Mesa Laboratories Inc

상장일Feb 29, 1984

CEOOwens (Gary M)

직원 수730

유형Ordinary Share

회계 연도 종료Feb 29

주소12100 W 6th Ave

도시LAKEWOOD

증권 거래소NASDAQ OMX - NASDAQ BASIC

국가United States of America

우편 번호80228

전화13039878000

웹사이트https://mesalabs.com

종목 코드 MLAB

상장일Feb 29, 1984

CEOOwens (Gary M)

Mesa Laboratories Inc의 회사 임원진



이름

이름/직위

직위

주식 보유

변동

Mr. Gary M. Owens

President, Chief Executive Officer, Director

148.26K

+8.45%

Dr. John James Sullivan, Ph.D.

Independent Chairman of the Board

70.06K

-2.78%

Mr. John V. Sakys

Chief Financial Officer, Vice President

41.70K

+31.03%

Mr. Brian Archbold

Senior Vice President - Continuous Improvement

Mr. Shiraz S. Ladiwala

Lead Independent Director

Mr. Mark Christophe Capone

Independent Director

Ms. Jennifer S. Alltoft

Independent Director

Mr. R. Tony Tripeny

Independent Director

Ms. Shannon M. Hall

Independent Director

이름

이름/직위

직위

주식 보유

변동

Mr. Gary M. Owens

President, Chief Executive Officer, Director

148.26K

+8.45%

Dr. John James Sullivan, Ph.D.

Independent Chairman of the Board

70.06K

-2.78%

Mr. John V. Sakys

Chief Financial Officer, Vice President

41.70K

+31.03%

Mr. Brian Archbold

Senior Vice President - Continuous Improvement

Mr. Shiraz S. Ladiwala

Lead Independent Director

Mr. Mark Christophe Capone

Independent Director

수익 분석

통화: USD마지막 업데이트: Mon, Oct 6

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Discrete Revenues- Consumables

35.77M

60.08%

Discrete Revenues- Hardware and Software

12.57M

21.11%

Contracted Revenues- Services

7.90M

13.26%

Discrete Revenues- Services

3.31M

5.55%

지역별USD

이름

수익

비율

United States

27.65M

46.43%

Other

26.47M

44.45%

China

5.43M

9.12%

사업별

지역별

사업별USD

이름

수익

비율

Discrete Revenues- Consumables

35.77M

60.08%

Discrete Revenues- Hardware and Software

12.57M

21.11%

Contracted Revenues- Services

7.90M

13.26%

Discrete Revenues- Services

3.31M

5.55%

주식 보유 통계

마지막 업데이트: Sun, Nov 16

주주

주주 유형

주주

비율

Conestoga Capital Advisors, LLC

7.72%

BlackRock Institutional Trust Company, N.A.

5.93%

The Vanguard Group, Inc.

5.83%

Ranger Investment Management, L.P.

3.80%

Geneva Capital Management LLC

3.47%

기타

73.26%

주주

비율

Conestoga Capital Advisors, LLC

7.72%

BlackRock Institutional Trust Company, N.A.

5.93%

The Vanguard Group, Inc.

5.83%

Ranger Investment Management, L.P.

3.80%

Geneva Capital Management LLC

3.47%

기타

73.26%

주주 유형

주주

비율

Investment Advisor

37.82%

Investment Advisor/Hedge Fund

35.41%

Hedge Fund

13.57%

Individual Investor

5.44%

Research Firm

4.14%

Bank and Trust

0.88%

Pension Fund

0.84%

Sovereign Wealth Fund

0.06%

Insurance Company

0.03%

기타

1.82%

기관 주식 보유



마지막 업데이트: Wed, Oct 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q3

387

5.12M

92.75%

-722.23K

2025Q2

399

5.60M

101.85%

-541.53K

2025Q1

415

5.83M

106.86%

-307.02K

2024Q4

405

5.76M

105.94%

-86.00K

2024Q3

413

5.30M

97.90%

-538.92K

2024Q2

412

5.31M

98.26%

-376.30K

2024Q1

404

5.28M

97.81%

-366.78K

2023Q4

400

5.27M

97.82%

-295.14K

2023Q3

392

5.33M

99.02%

-178.63K

2023Q2

390

5.31M

98.92%

-355.72K

주주 활동



이름

보유 주식

비율

변동

Chg %

날짜

Conestoga Capital Advisors, LLC

566.15K

10.29%

-5.21K

-0.91%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

708.66K

12.88%

-30.52K

-4.13%

Jun 30, 2025

The Vanguard Group, Inc.

388.10K

7.05%

+4.80K

+1.25%

Jun 30, 2025

Ranger Investment Management, L.P.

214.29K

3.9%

-16.70K

-7.23%

Jun 30, 2025

Geneva Capital Management LLC

199.09K

3.62%

+9.78K

+5.17%

Jun 30, 2025

Royce Investment Partners

247.61K

4.5%

-23.51K

-8.67%

Jun 30, 2025

Owens (Gary M)

136.70K

2.48%

+13.43K

+10.89%

Jun 21, 2025

Janus Henderson Investors

113.28K

2.06%

+32.54K

+40.30%

Jun 30, 2025

Atlanta Capital Management Company, L.L.C.

145.94K

2.65%

-1.85K

-1.25%

Jun 30, 2025

주식 배당금



지난 5년 동안 총 16.82M USD의 배당금이 분배되었습니다.

날짜

배당금

기준일

지급일

배당락일

Oct 03, 2025

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2025 going ex on Nov 28, 2025

Nov 28, 2025

Dec 15, 2025

Nov 28, 2025

Jul 03, 2025

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2025 going ex on Aug 29, 2025

Aug 29, 2025

Sep 15, 2025

Aug 29, 2025

Apr 07, 2025

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 16, 2025 going ex on May 30, 2025

May 30, 2025

Jun 16, 2025

May 30, 2025

Jan 08, 2025

MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 17, 2025 going ex on Feb 28, 2025

Feb 28, 2025

Mar 17, 2025

Feb 28, 2025

Oct 02, 2024

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 16, 2024 going ex on Nov 29, 2024

Nov 29, 2024

Dec 16, 2024

Nov 29, 2024

Jul 10, 2024

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 16, 2024 going ex on Aug 30, 2024

Aug 30, 2024

Sep 16, 2024

Aug 30, 2024

Apr 05, 2024

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 14, 2024 going ex on May 31, 2024

May 31, 2024

Jun 14, 2024

May 31, 2024

Jan 04, 2024

MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 15, 2024 going ex on Feb 28, 2024

Feb 29, 2024

Mar 15, 2024

Feb 28, 2024

Oct 03, 2023

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2023 going ex on Nov 29, 2023

Nov 30, 2023

Dec 15, 2023

Nov 29, 2023

Jul 05, 2023

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2023 going ex on Aug 30, 2023

Aug 31, 2023

Sep 15, 2023

Aug 30, 2023

주식 분할



날짜

유형

비율

데이터 없음

날짜

유형

비율

데이터 없음

자주 묻는 질문

Mesa Laboratories Inc의 상위 5대 주주는 누구인가요?



Mesa Laboratories Inc의 상위 5대 주주는 다음과 같습니다:
Conestoga Capital Advisors, LLC는 566.15K주의 주식을 보유하고 있으며, 전체 주식의 10.29%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 708.66K주의 주식을 보유하고 있으며, 전체 주식의 12.88%를 차지합니다.
The Vanguard Group, Inc.는 388.10K주의 주식을 보유하고 있으며, 전체 주식의 7.05%를 차지합니다.
Ranger Investment Management, L.P.는 214.29K주의 주식을 보유하고 있으며, 전체 주식의 3.90%를 차지합니다.
Geneva Capital Management LLC는 199.09K주의 주식을 보유하고 있으며, 전체 주식의 3.62%를 차지합니다.